Recombinant multi-species iNOS/NOS2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine iNOS/NOS2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
The Alternative Names of target: HEP-NOS,Hepatocyte NOS (HEP-NOS),INOS,Inducible NO synthase (Inducible NOS,MAC-NOS,NOS,NOS type II,NOS-II,NOS2,NOS2A,Nitric oxide synthase,Nos-2,Nos2,Nos2a,Peptidyl-cysteine S-nitrosylase NOS2,i-NOS,iNOS,iNOS),iNos,inducible

Target products collectionGo to iNOS/NOS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T02703-Ag-1/ GM-Tg-hg-T02703-Ag-2 Human iNOS/NOS2 protein Human
GM-Tg-rg-T02703-Ag-1/ GM-Tg-rg-T02703-Ag-2 Rat iNOS/NOS2 protein Rat
GM-Tg-mg-T02703-Ag-1/ GM-Tg-mg-T02703-Ag-2 Mouse iNOS/NOS2 protein Mouse
GM-Tg-cynog-T02703-Ag-1/ GM-Tg-cynog-T02703-Ag-2 Cynomolgus/Rhesus macaque iNOS/NOS2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T02703-Ag-1/ GM-Tg-felg-T02703-Ag-2 Feline iNOS/NOS2 protein Feline
GM-Tg-cang-T02703-Ag-1/ GM-Tg-cang-T02703-Ag-2 Canine iNOS/NOS2 protein Canine
GM-Tg-bovg-T02703-Ag-1/ GM-Tg-bovg-T02703-Ag-2 Bovine iNOS/NOS2 protein Bovine
GM-Tg-equg-T02703-Ag-1/ GM-Tg-equg-T02703-Ag-2 Equine iNOS/NOS2 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T02703-Ag-1/ GM-Tg-hg-T02703-Ag-2; GM-Tg-rg-T02703-Ag-1/ GM-Tg-rg-T02703-Ag-2;
GM-Tg-mg-T02703-Ag-1/ GM-Tg-mg-T02703-Ag-2; GM-Tg-cynog-T02703-Ag-1/ GM-Tg-cynog-T02703-Ag-2;
GM-Tg-felg-T02703-Ag-1/ GM-Tg-felg-T02703-Ag-2; GM-Tg-cang-T02703-Ag-1/ GM-Tg-cang-T02703-Ag-2;
GM-Tg-bovg-T02703-Ag-1/ GM-Tg-bovg-T02703-Ag-2; GM-Tg-equg-T02703-Ag-1/ GM-Tg-equg-T02703-Ag-2
Products Name iNOS/NOS2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name iNOS/NOS2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine iNOS/NOS2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.